Other clinical transplantNew Strategies in Immunosuppression
References (31)
- et al.
Tolerogenic immunosuppression for organ transplantation
Lancet
(2003) - et al.
Prospective study on late consequences of subclinical non-compliance with immunosuppressive therapy in renal transplant patients
Am J Transplant
(2004) - et al.
Risk/benefit evaluation of Tacrolimus (TAC) vs cyclosporine microemulsion (CsA) after cardiac transplantation18-month results
J Heart Lung Transplant
(2004) What’s in the pipeline? New immunosuppressive drugs in transplantation
Am J Transplant
(2002)- et al.
Leflunomide and malononitrilamides
Am J Med Science
(1997) - 2003 OPTN/SRTR Annual Report 1993-2002: HHS/HRSA/SPB/DOT; UNOS;...
- et al.
Tailoring immunosuppressive therapy
Nephrol Dial Transplant
(2002) - et al.
Monitoring immunosuppressive drugsHas it a future?
Ther Drug Monit
(2004) - et al.
The pharmacogenetics of immunosuppression for organ transplantationA Route to Individualization of Drug Administration
Am J Pharmacogenomics
(2003) - et al.
Association of the multidrug resistance-1 gene single-nucleotide polymorphisms with the tacrolimus dose requirements in renal transplant recipients
J Am Soc Nephrol
(2003)
Personality disordersa challenge for transplantation
Prog Transplant
(2000)
Psychosocial and behavioral selection criteria for solid organ transplantation
Prog Transplant
(2001)
New drugs to improve transplant outcomes
Transplantation
(2004)
Conversion of stable kidney transplant recipients from a twice daily Prograf based regimen to a once daily modified release tacrolimus based regimen
Transplantation
(2004)
Conversion of stable liver transplant recipients from a twice daily Prograf based regimen to a once daily modified release tacrolimus based regimen
Transplantation
(2004)
Cited by (0)
Copyright © 2005 Elsevier Inc. All rights reserved.